DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Radiation: Arm 2 Weekly Boost of Radiation Therapy
Radiation: Arm 1 Daily Boost of Radiation Therapy

First Posted Date: 2012-05-04

Last Posted Date: 2021-01-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 433

Registration Number: NCT01591811

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke

Not Applicable

Completed

Conditions: Stroke With Hemiparesis

Interventions: Other: Music & Physical Therapy

First Posted Date: 2012-04-26

Last Posted Date: 2017-07-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT01586221

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Using Nudges to Implement Comparative Effectiveness

Completed

Conditions: Hypercholesterolemia

Interventions: Behavioral: Nudge

First Posted Date: 2012-04-11

Last Posted Date: 2015-08-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT01575171

Locations: 🇺🇸
Murray Hill Medical Group, New York, New York, United States

Starting Early Obesity Prevention Program

Not Applicable

Completed

Conditions: Childhood Obesity

Interventions: Behavioral: Family groups

First Posted Date: 2012-03-01

Last Posted Date: 2024-08-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 338

Registration Number: NCT01541761

Locations: 🇺🇸
Bellevue Hospital Center Ambulatory Care Clinic, New York, New York, United States

Aprepitant Effects in Intravenous Heroin Dependence

Phase 1

Completed

Conditions: Opioid Dependence

Interventions: Drug: Placebo pill
Drug: Aprepitant

First Posted Date: 2012-02-07

Last Posted Date: 2021-08-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 64

Registration Number: NCT01527994

Locations: 🇺🇸
Bellevue Hospital Center & the NYU School of Medicine, New York, New York, United States

Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

Not Applicable

Completed

Conditions: Herpes Zoster

Interventions: Other: Choosing to receive the vaccine

First Posted Date: 2011-12-01

Last Posted Date: 2013-08-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 170

Registration Number: NCT01483378

Locations: 🇺🇸
Bellevue Hospital, New York, New York, United States
🇺🇸
NYU Langone Medical Center, New York, New York, United States

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Not Applicable

Completed

Conditions: Myocardial Ischemia
Cardiovascular Diseases
Coronary Disease
Coronary Artery Disease
Heart Diseases

Interventions: Procedure: cardiac catheterization
Behavioral: Lifestyle
Procedure: coronary artery bypass graft surgery
Procedure: percutaneous coronary intervention
Drug: Medication

First Posted Date: 2011-11-15

Last Posted Date: 2023-06-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5179

Registration Number: NCT01471522

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
VA Palo Alto HealthCare System, Palo Alto, California, United States
🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

and more 317 locations

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Velcade
Drug: Cyclophosphamide
Drug: Chloroquine

First Posted Date: 2011-09-21

Last Posted Date: 2020-02-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 11

Registration Number: NCT01438177

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

Not Applicable

Completed

Conditions: Ulcerative Colitis

Interventions: Drug: Trichuris suis ova

First Posted Date: 2011-09-14

Last Posted Date: 2016-07-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 4

Registration Number: NCT01433471

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Patient-Provider Communication and Medication Adherence

Completed

Conditions: Hypertension

First Posted Date: 2011-09-02

Last Posted Date: 2017-10-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 114

Registration Number: NCT01428011

Locations: 🇺🇸
Bellevue Hospital Ambulatory Care Practive, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy